Literature DB >> 12921819

Differences in psychosocial and behavioral profiles between heart failure patients admitted to cardiology and geriatric wards.

Sabina De Geest1, Lieve Scheurweghs, Isabelle Reynders, Walter Pelemans, Walter Droogné, Johan Van Cleemput, Marcia Leventhal, Johan Vanhaecke.   

Abstract

BACKGROUND: Heart failure represents a growing epidemic, primarily in the elderly. Development and implementation of management programs designed for use in daily clinical practice remains a major challenge. AIMS: This study aimed at profiling a hospitalized heart failure population in view of medical, behavioral, educational, psychosocial and health resources utilization parameters stratified by admission to cardiology and geriatric wards. METHODS AND
RESULTS: Using a descriptive comparative design, 109 European heart failure patients admitted to cardiology (42%) and geriatric wards (58%) were included. Significant differences (all P<0.0001) were identified between the two groups. Patients admitted to cardiology had a mean age of 68.5, 33% were women, and the mean ejection fraction was 38%. Patients admitted to geriatrics had a mean age of 85, 68% were women, and the mean ejection fraction was 56%. Sixty-six percent were admitted for cardiac reasons. Medical, educational, behavioral, psychosocial and health resources utilization data were retrieved from medical files as well as by patient and family interviews. Results showed significant differences between groups. Patients admitted to geriatric wards received significantly less ACE inhibition and beta-blockers. Moreover, these patients were significantly less knowledgeable, showed poorer self-management, poorer hearing, more cognitive impairment, a higher degree of depressive symptomatology, more problems with ADL and IADL, and used significantly more home health care services compared to patients admitted to cardiology wards.
CONCLUSION: The characteristics of the heart failure population at large are quite different from those of populations included in large-scale therapeutic trials. Findings from this study provide options for tailored management strategies for both profiled subgroups.

Entities:  

Mesh:

Year:  2003        PMID: 12921819     DOI: 10.1016/s1388-9842(02)00298-2

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  5 in total

1.  Executive dysfunction is independently associated with reduced functional independence in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Manfred van Dulmen; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Nurs       Date:  2013-05-08       Impact factor: 3.036

2.  Utility of the Millon Behavioral Medicine Diagnostic to predict medication adherence in patients diagnosed with heart failure.

Authors:  Kristen Farrell; Biing-Jiun Shen; Stephen Mallon; Frank J Penedo; Michael H Antoni
Journal:  J Clin Psychol Med Settings       Date:  2011-03

3.  Cognitive impairment is independently associated with reduced instrumental activities of daily living in persons with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Cardiovasc Nurs       Date:  2012 Jan-Feb       Impact factor: 2.083

Review 4.  Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.

Authors:  Donatella Del Sindaco; Maria Denitza Tinti; Luca Monzo; Giovanni Pulignano
Journal:  Clin Interv Aging       Date:  2010-12-03       Impact factor: 4.458

5.  Reduced cognitive function predicts functional decline in patients with heart failure over 12 months.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Eur J Cardiovasc Nurs       Date:  2013-06-09       Impact factor: 3.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.